Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HIP is a healthcare-focused venture capital firm founded to create a community of seasoned investors. Established in the United States, HIP aims to support innovative healthcare startups by leveraging a network that includes both non-institutional and institutional investors. The firm emphasizes a collaborative approach to investment, enabling collective decision-making and due diligence.
Currently, HIP has over 275 members, including 90 institutional investors and 18 health system strategic investors. The firm has a portfolio count of 10 companies and operates across various stages from pre-seed to growth equity. HIP's notable milestones include building a strong community of investors and establishing a reputation for supporting disruptive healthcare innovations.
HIP invests in disruptive healthcare startups, particularly in the medtech and healthtech sectors. The firm employs a community-based diligence approach, which allows for collective decision-making and shared insights among its investors. This strategy enables HIP to identify and support startups effectively, providing access to multiple forms of capital.
The investment strategy is characterized by a full lifecycle venture model, which includes guidance from industry experts throughout the investment process. HIP looks for startups that demonstrate innovative solutions to pressing healthcare challenges, emphasizing the importance of collaboration and expertise in their investment decisions.
HIP's portfolio includes a range of innovative healthcare companies:
Santosh Mohan: Vice President, Innovation and New Ventures at Advocate Health, brings extensive experience in healthcare innovation.
Tosan Boyo: President at Sutter Health East Bay, has a strong background in healthcare management and strategy.
Dr. Tracy Dooley: Venture Partner at Avestria Ventures, specializes in healthcare investments and has a medical background.
Keith Winter: Partner at Teal Ventures, focuses on early-stage investments in healthcare.
Christine Brocato: SVP, Strategic Innovation at CommonSpirit Health, has expertise in healthcare strategy and innovation.
Dr. Kate Wolin: Partner at PACE Healthcare Capital, brings a wealth of knowledge in healthcare investments.
Kristina Emery: Principal at Corewell Health Ventures, focuses on healthtech investments.
Yuri Sudhakar: Healthcare Investor and Advisor, has a strong track record in healthcare venture capital.
To pitch HIP, founders should visit healthinnovationpitch.com and submit their proposals through the provided channels. The firm prefers detailed decks that outline the startup's vision, market opportunity, and team qualifications. Response times may vary, but HIP encourages warm introductions through their network when possible.
In recent months, HIP has actively expanded its community of seasoned investors, now comprising over 275 members. This includes 90 institutional investors and 18 health system strategic investors, highlighting the firm's collaborative investment approach.
HIP continues to build its portfolio, focusing on innovative healthcare companies that align with its investment thesis. The firm emphasizes the importance of community and collaboration in supporting disruptive healthcare startups.
What are HIP's investment criteria?
HIP focuses on disruptive healthcare startups, particularly in the medtech and healthtech sectors. They look for innovative solutions that address significant healthcare challenges.
How can I pitch to HIP?
Founders can submit their pitches through the HIP website at healthinnovationpitch.com. The firm encourages a collaborative approach, so detailed information about the startup and its market potential is essential.
What makes HIP different from other VC firms?
HIP emphasizes a community-based diligence approach, allowing for collective decision-making among its investors. This model enhances the support and resources available to portfolio companies.
What is HIP's geographic focus?
HIP primarily invests in startups based in the United States, focusing on healthcare innovations that can scale within the domestic market.
What is the typical check size for investments?
While specific check sizes are not disclosed, HIP invests across various stages, from pre-seed to growth equity, indicating a flexible approach to funding amounts based on the startup's needs.
What kind of post-investment support does HIP provide?
HIP offers guidance from industry experts and access to a network of seasoned investors, which can help startups navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.